Shared Care: Listed Alphabetically
Statement for Requests for Shared Care Agreements for Historic Patients
SCA’s are currently listed alphabetically by drug name (or disease). Where a drug doesn’t have it’s own specific request form please use this one Shared Care Request Form. This generic shared care request form is based on the national SCA forms and will be in use from the 3rd January 2023.
A programme of review of these shared care agreement documents is currently being undertaken. These are the current shared care agreements. If there are any concerns please contact [email protected] Please do not send patient identifiable information as email may be unsecure.
(A) – Full Shared Care Agreement (B) – Shared Care Request Form
(B) Generic New Request Form National Format
(A) ADHD (paediatric) SCA (B) New Request Form National Format
(A) Agomelatine SCA (B) New Request Form National Format
(A) Allergen Specific Sublingual Immunotherapy (Acarizax, Grazax and Itulazax) in Adults SCA (B) New Request form National Format
(A) Allergen Specific Sublingual Immunotherapy (Acarizax, Grazax and Itulazax) in Paediatrics SCA (B) New Request form National Format
(A) Apomorphine SCA
(A) Atomoxetine (adults) SCA (B) New Request Form National Format
(A) Atomoxetine (paediatric) SCA
(A) Azathioprine (dermatology) (B) New Request Form National Format
(A) Azathioprine (adult gastroenterology) SCA
(A) Azathioprine (paediatric gastroenterology) SCA
(A) Azathioprine Neurology SCA (B) New Request Form National Format
(A) Azathioprine (rheumatology) (B) New Request Forms National Format
(A) Ciclosporin (dermatology) SCA (B) New Request Forms National Format
(A) Dantrolene SCA
(A) Denosumab for osteoporosis SCA (B) New Request Forms National Format
(A) Denosumab for prevention of skeletal events with bone metastases SCA (B) New Request Form National Format
(A) Dexamfetamine (adults) SCA (B) New Request Form National Format
(A) Guanfacine (adult) SCA (B) New Request Form National Format
(A) Guanfacine (paediatric) SCA
(A) Leflunomide SCA (B) New Request form National Format
(A) Lisdexamfetamine (adults) SCA (B) New Request Form National Format
(A) Lisdexamfetamine (paediatric) SCA
(A) Lithium SCA (B) New Request Form National Format
(A) Mercaptopurine (paediatric gastroenterology) SCA
(A) Mercaptopurine (adult gastroenterology) SCA
(A) Methotrexate oral (Rheum/Derm/Gastro) SCA
(B) Methotrexate – New Request Form National Format Dermatology
(B) Methotrexate – New Request Form National Format Gastroenterology
(B) Methotrexate – New Request Form National Format Rheumatology
(A) Methylphenidate (adults) SCA (B) New Request Form National Format
(A) Methylphenidate (paediatric) SCA
(A) Mycophenolate Mofetil (Rheum/Derm/Resp/Neuro) SCA
(B) Mycophenolate Mofetil – New Request Form National Format Rheumatology
(B) Mycophenolate Mofetil – New Request Form National Format Dermatology
(B) Mycophenolate Mofetil – New Request Form National Format Neurology
(B) Mycophenolate Mofetil – New Request Form National Format Respiratory
(A) Mycophenolate for Historic Renal Transplant Patients
(A) Paediatric Cardiology Medications SCA
(A) Penicillamine (rheumatology) SCA (B) New Request Form National Format
(A) Riluzole SCA
(A) Sulfasalazine oral (rheumatology) SCA (B) New Request Form National Format
(A) Sulfasalazine oral and rectal (gastroenterology) SCA